Related Experiment Video
Updated: Feb 3, 2026

08:44
Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
12.7K
Autophagy Activation in Asthma Airways Remodeling
Kielan D McAlinden1,2,3, Deepak A Deshpande4, Saeid Ghavami5
11 Graduate School of Health and.
American Journal of Respiratory Cell and Molecular Biology
|November 2, 2018
Summary
Current asthma treatments do not address airway remodeling. This study shows autophagy is dysregulated in asthma and inhibiting it with chloroquine reduces airway remodeling and inflammation in mice.
Area of Science:
- Cellular Biology
- Immunology
- Respiratory Medicine
Background:
- Current asthma therapies do not target airway remodeling, a key factor in disease progression and lung function loss.
- Macroautophagy (autophagy), a fundamental cellular process, appears dysregulated in asthma, suggesting a potential therapeutic target.
Purpose of the Study:
- To investigate the relationship between autophagy and airway remodeling in asthma.
- To evaluate the preclinical efficacy of an autophagy inhibitor, chloroquine, in murine asthma models.
Main Methods:
- Human asthmatic and nonasthmatic lung tissues were analyzed for histological features of airway remodeling and expression of autophagy markers (Beclin-1, ATG5, p62).
- Autophagy inhibition using chloroquine was tested in prophylactic and treatment models of allergic asthma in mice, assessing airway inflammation, hyperresponsiveness, and remodeling.
Main Results:
- Asthmatic human lung tissues exhibited significant airway remodeling, including thickened epithelium, increased lamina propria depth, and larger airway smooth muscle bundles.
- Higher expression of autophagy markers Beclin-1 and ATG5, and reduced p62, were observed in asthmatic tissues, with elevated Beclin-1 in epithelial and ciliated cells.
- Chloroquine treatment effectively reduced airway inflammation, hyperresponsiveness, and airway remodeling in murine asthma models.
Conclusions:
- Autophagy is selectively activated in structural cells in asthma in a context-dependent manner.
- Targeting the autophagy pathway with inhibitors like chloroquine shows promise for ameliorating airway remodeling in asthma.
Related Concept Videos
Nucleosome Remodeling
11.2K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.2K
Autophagy
5.9K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K

